The BSSC will a) enter into agreements with medical institutions (sites) to enroll research participants and collect biospecimens, b) provide study activation, training, coordination, and assistance, c) provide reimbursement for biospecimen acquisition, data acquisition, and participant and provider engagement activity, and d) invoice Leidos Biomed for those activities. Sites will primarily be members of the NCI National Community Oncology Research Program (NCORP). The project will utilize five or more sites in 2019, up to 55 in 2020, and adding up to 100 sites in 2021, depending on 1) patient recruitment, 2) sample submission, and 3) contractual and programmatic discussions with NCI. Leidos Biomed expects up to 150 sites may be engaged in total for the Biobank project.
Leidos Biomedical Research, Inc.
Mrs. Carol Caballero
Proposal Due Date:
Friday, July 12, 2019
Research & Development Services & Subcontracts
NCI OA Contract Number:
HHSN261201500003I - IDIQ
Questions are due on 6/14/19. A bidder's Telecon will occur on 6/20/19 at 3 pm ET. The proposal is due at 2 pm ET on 7/12/19. Please contact Carol Caballero for a copy of the solicitation.